Detalhe da pesquisa
1.
First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations.
Eur J Cancer
; 199: 113556, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271745
2.
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer.
J Thorac Oncol
; 19(5): 803-817, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096950
3.
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study.
J Thorac Oncol
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278303
4.
A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
BMC Pulm Med
; 13: 55, 2013 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23987478
5.
Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer - A multicenter observational analysis.
Lung Cancer
; 179: 107184, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37040677
6.
Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment - A multicenter analysis.
Lung Cancer
; 170: 165-175, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803041
7.
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
Eur J Cancer
; 170: 106-118, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598358
8.
KRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma.
Transl Lung Cancer Res
; 10(2): 737-752, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718018
9.
Corrigendum to "First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations" [Eur J Cancer 199 (2024) 113556].
Eur J Cancer
; : 114130, 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38789333
10.
Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
Genome Med
; 10(1): 55, 2018 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30029672
11.
Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
J Clin Oncol
; 23(18): 4048-56, 2005 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15961758
12.
Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group.
J Clin Oncol
; 23(25): 6181-9, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16135485
13.
Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients.
J Thorac Oncol
; 11(1): 122-7, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26762747
14.
Secondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and Adolescence.
Dtsch Arztebl Int
; 112(18): 320-7, i, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26037468
15.
The impact of central review and central therapy planning on the treatment of children and adolescents with Hodgkin lymphoma.
Eur J Cancer
; 50(2): 425-33, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24157256
16.
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.
J Clin Oncol
; 31(12): 1562-8, 2013 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23509321
17.
Treatment of Hodgkin's lymphoma in childhood and adolescence without radiotherapy.
Transl Pediatr
; 2(3): 131-2, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26835305
18.
Reply to A.S. Reese.
J Clin Oncol
; 31(28): 3610-1, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24002521
19.
Proliferation characteristics in pediatric Hodgkin's lymphoma point to a cell cycle arrest in the G(1) phase.
Mod Pathol
; 18(11): 1440-7, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16056247